Retrieve available abstracts of 198 articles: HTML format
Single Articles
July 2025
ELBAZ T, Al-Naamani K, Abosheaishaa H, Alswat K, et al Leading Role of Sofosbuvir/Daclatasvir in Achieving Hepatitis C Elimination in
Egypt.
J Viral Hepat. 2025;32:e70032. PubMedAbstract available
MAUNG ST, Chaiteerakij R Scoping Review on Strategies for Safe Nucleot(s)ide Analogue Discontinuation and
Optimising Functional Cure in Chronic Hepatitis B.
J Viral Hepat. 2025;32:e70040. PubMedAbstract available
FREELAND C, Plunkett Q, Sirapu S, Cohen C, et al A Person-Centered Hepatitis B Approach Using the COM-B Model to Understand
Barriers and Facilitators of Hepatitis B Testing, Management and Treatment.
J Viral Hepat. 2025;32:e70041. PubMedAbstract available
RAMIER C, Carrat F, Beo VD, Parlati L, et al Unhealthy Behaviours and All-Cause Mortality Among People With Chronic Hepatitis
B, With and Without Hepatitis Delta (ANRS CO22 HEPATHER).
J Viral Hepat. 2025;32:e70033. PubMedAbstract available
SHIHA G, Helmy A, Mikhail N, Hassan A, et al Long Term Clinical Outcomes in Chronic Hepatitis C Patients Who Achieved SVR
Following DAAs: A Decade Long Prospective Study.
J Viral Hepat. 2025;32:e70044. PubMedAbstract available
ADEBAJO A, Qiao S, Esu I, Olatosi B, et al The Efficacy and Sustainability of an Implementation Intervention (FOCUS Program)
on Linkage to Hepatitis C Care Time at a Community Health Center in the Deep
South: A Longitudinal Study Based on Electronic Medical Records.
J Viral Hepat. 2025;32:e70045. PubMedAbstract available
YARDENI D, Cividalli O, Itkowitz B, Lipnizkiy I, et al Impact of Universal Screening for HDV in HBV-Infected Patients on Chronic HDV
Detection Rate in Israel.
J Viral Hepat. 2025;32:e70046. PubMedAbstract available
RAYNER D, McCullough F, McQue K, Jones K, et al Prospective Evaluation of Blood Borne Virus Testing in Custody Suites in
North-East England.
J Viral Hepat. 2025;32:e70042. PubMedAbstract available
June 2025
MARLOWE EM, Swanson BE, Realegeno SE, Meyer WA 3rd, et al Epidemiological Burden of Hepatitis Delta Virus in the United States.
J Viral Hepat. 2025;32:e70029. PubMedAbstract available
LI S, Dong W, Yu Y, Yang Z, et al A Government-Led, Patient-Centric Strategy to Re-Engage Diagnosed but Untreated
Hepatitis C Patients in Yunnan Province, China.
J Viral Hepat. 2025;32:e70028. PubMedAbstract available
XU C, Yin DH, Han JH, Gao YN, et al Efficacy of Traditional Chinese Medicine External Therapies in Treating Insomnia
in Patients With Chronic Hepatitis B: Systematic Review and Meta-Analysis.
J Viral Hepat. 2025;32:e70030. PubMedAbstract available
SANDMANN L, Windzio L, Bremer B, Falak S, et al Droplet Digital PCR: A Powerful Tool for Accurate Quantification of Hepatitis D
Virus RNA Levels and Verification of Detection Limits.
J Viral Hepat. 2025;32:e70036. PubMedAbstract available
HIRODE G, Kilany M, Pi S, Kim A, et al Chronic Hepatitis B Patients Referred for Liver Transplantation After
Nucleos(t)ide Analog Cessation.
J Viral Hepat. 2025;32:e70031. PubMedAbstract available
IACOB S, Chitul M, Stan D, Gheorghe D, et al Identifying Risk Factors for Hepatocellular Carcinoma in Patients With Delta
Hepatitis: A Prognostic Study.
J Viral Hepat. 2025;32:e70034. PubMedAbstract available
PENG Y, Song Y, Liu X, Du X, et al Host Factor SRSF7 Promotes HBV Replication Through Binding to and Stabilising
Viral pgRNA.
J Viral Hepat. 2025;32:e70024. PubMedAbstract available
SI NAFA SA, Benali S, Penaranda G, Deuffic-Burban S, et al Universal HCV Screening in Hospitalised Patients in France: It Could Be a Good
Option! The DEVICHO Study.
J Viral Hepat. 2025;32:e70038. PubMedAbstract available
MENDIZABAL M, Sabate CD, Gonzalez Ballerga E, Gruz F, et al Increasing Treatment Uptake for Chronic Hepatitis B in South America: A
Comparative Analysis of Country-Specific and WHO 2024 Guidelines.
J Viral Hepat. 2025;32:e70035. PubMedAbstract available
May 2025
WANG X, Yan X, He B, Li B, et al Global Burden and Trends of Acute Hepatitis C From 1990 to 2021: An Analysis
Based on the 2021 Global Burden of Disease Study.
J Viral Hepat. 2025;32:e70026. PubMedAbstract available
WONG NS, Chan DP, Wong GL, Lee SS, et al Cost-Effectiveness of Universal Screen-and-Treat Strategies for Reducing
Morbidity and Mortality of Chronic Hepatitis B in a High-Endemicity City.
J Viral Hepat. 2025;32:e70027. PubMedAbstract available
April 2025
INOUE J, Minami S, Abe K, Kida M, et al Validation Study of Scores Predicting Hepatocellular Carcinoma Risk in Chronic
Hepatitis B Patients Treated With Nucleos(t)ide Analogues.
J Viral Hepat. 2025;32:e70021. PubMedAbstract available
VAITTINADA AYAR P, Abdelkader J, Gay M, Allali R, et al Systematic Screening for Hepatitis B, C, and HIV and Linkage to Care in Patients
With Mental Health Disorders Admitted to the Emergency Department.
J Viral Hepat. 2025;32:e70018. PubMedAbstract available
AHMED S, Nadir MA, Farooqi HA, Ashraf H, et al Enhancing Hepatitis C Management: Mortality Trends and Disparities in the US by
Sex, Age Group, Race/Ethnicity and Region (1999-2020).
J Viral Hepat. 2025;32:e70011. PubMedAbstract available
JIA Y, Qi X, Yu X, Dong M, et al Accuracy of International Guidelines in Identifying Normal Liver Histology in
Chinese Patients With HBeAg-Positive Chronic HBV Infection.
J Viral Hepat. 2025;32:e14024. PubMedAbstract available
RONG X, Yang G, Xu Y, Chen H, et al Efficacy and Safety of Tenofovir Amibufenamide and Tenofovir Alafenamide for
First-Time HBV-Related Decompensated Cirrhosis.
J Viral Hepat. 2025;32:e14029. PubMedAbstract available
XUE K, Wen L, Ji X, Yan X, et al Impact of HBV Infection in Couples on In Vitro Fertilisation-Embryo Transfer
Outcomes and Clinical Characteristics of Newborns: A Retrospective Study Based on
3900 Infertile Couples.
J Viral Hepat. 2025;32:e70015. PubMedAbstract available
AN W, Li M, Luo J, Yu Z, et al Prognosis of Acute HEV Infection in Patients With Liver Cirrhosis: A
Retrospective Study of 628 Chinese Patients.
J Viral Hepat. 2025;32:e14018. PubMedAbstract available
SUN J, Kelly M, Tsheten T, Pourmarzi D, et al Prevalence of Hepatitis C Among Migrants: A Systematic Review and Meta-Analysis.
J Viral Hepat. 2025;32:e70025. PubMedAbstract available
HARDTKE S, Yurdaydin C, Caruntu FA, Curescu MG, et al Frequency, Severity and Impact of Pegylated Interferon Alpha-Associated Flares in
Hepatitis D Infection.
J Viral Hepat. 2025;32:e70022. PubMedAbstract available
LIANG H, Zheng X, Liu Y, Mao Q, et al Effects of Different Antiviral Treatments on Liver Inflammation and Fibrosis in
Patients With Chronic Hepatitis B.
J Viral Hepat. 2025;32:e70019. PubMedAbstract available
HUI RW, Wong DK, Mak LY, Fung J, et al Development and Validation of a High-Sensitivity Droplet Digital PCR Assay for
Serum Hepatitis B Virus DNA Detection.
J Viral Hepat. 2025;32:e70023. PubMedAbstract available
POWELL AA, Costella A, Roche R, Leeman D, et al Sensitivity Analysis of Hepatitis B and C Mortality in England Using Data
Linkage: Meeting the WHO Elimination Threshold for Mortality.
J Viral Hepat. 2025;32:e70016. PubMedAbstract available
March 2025
BARRE T, Ramier C, Ory K, Saidi T, et al Liver Enzyme Elevation After Hepatitis C Virus Cure: Is There a Sex Effect? (ANRS
CO13 HEPAVIH Cohort).
J Viral Hepat. 2025;32:e70007. PubMed
EILARD A, Ringlander J, Andersson ME, Nilsson S, et al Long-Term Outcome of Chronic Hepatitis B-Histological Score and Viral Genotype
Are Important Predictors of Hepatocellular Carcinoma.
J Viral Hepat. 2025;32:e70008. PubMedAbstract available
PARK C, Hwang G, Choi WM, Han JE, et al Baseline Alpha-Fetoprotein Elevation and the Risk of Hepatocellular Carcinoma in
Chronic Hepatitis B: A Multicentre Cohort Study.
J Viral Hepat. 2025;32:e70006. PubMedAbstract available
KOGIAS D, Gavriilidis E, Antoniadou C, Skeva A, et al Hepatitis E Infection in Immunocompromised Patients Previously Treated With
Rituximab.
J Viral Hepat. 2025;32:e70005. PubMedAbstract available
CHELOUAH S, Nna H, Angijiro P, Thomas F, et al Screening, Prevalence and Management of Chronic Viral Hepatitis C in Mental
Health Setting: Towards the Eradication of A Forgotten Reservoir.
J Viral Hepat. 2025;32:e70014. PubMedAbstract available
WANG H, Xu C, Yao R, Zhang W, et al Single-Cell Transcriptome Identifies a Proinflammatory B-Cell Subset in Hepatitis
B Virus Associated Acute-on-Chronic Liver Failure.
J Viral Hepat. 2025;32:e70012. PubMedAbstract available
ZOU H, Zhu L, Cao L, Suo S, et al Vertical Transmission in Mothers Taking TAF With Exceptionally High Viral Load.
J Viral Hepat. 2025;32:e70000. PubMedAbstract available
JUON HS, Yang D, Fang CX, Hann HW, et al Perceived HBV-Related Stigma Is Associated With Lower Antiviral Medication
Adherence in Patients With Chronic Hepatitis B.
J Viral Hepat. 2025;32:e70010. PubMedAbstract available
ZHANG Y, Jin D, Zhu H, Lin M, et al Hepatocytes and Hepatic Stellate Cells Carry Different Levels of DNA Damage due
to Their Sensitivity to Oxidative Stress in Chronic Hepatitis B.
J Viral Hepat. 2025;32:e70017. PubMedAbstract available
February 2025
WANG H, Wang J, Zhang S, Zhang S, et al Clinical Features and Transition of Acute Hepatitis B Virus Infection.
J Viral Hepat. 2025;32:e14048. PubMedAbstract available
ZHANG Z, Wang J, Zhu L, Li Y, et al Optimization of the Use of APRI and FIB-4 for Ruling Out Liver Cirrhosis in
Chronic Hepatitis B Patients With Normal Alanine Aminotransferase.
J Viral Hepat. 2025;32:e14057. PubMedAbstract available
EMERY H, Evans C, Jack K, Martello E, et al A Qualitative Systematic Review of Barriers and Facilitators to Hepatitis B and C
Programmes in Prisons.
J Viral Hepat. 2025;32:e14049. PubMedAbstract available
MUTIMER D, Brown M, Logan J, Kelgeri C, et al Patient Source of Referral Is a Key Determinant of Subsequent Retention in Care
for Young Chronic Hepatitis B Patients.
J Viral Hepat. 2025;32:e14059. PubMedAbstract available
PERERA H, Imsirovic H, Macphail G, Webster D, et al Resistance-Associated Substitution Testing Trends and Impact on HCV Treatment
Outcomes in Canada: A CanHepC-CANUHC Analysis.
J Viral Hepat. 2025;32:e14058. PubMedAbstract available
SINGAL AG, Reddy KR, Colombo M, Morris HL, et al DAA-PASS: A Prospective Evaluation of HCC Recurrence After Direct Acting
Antiviral Therapy.
J Viral Hepat. 2025;32:e14056. PubMedAbstract available
HILTON B, De Angelis D, Mitchell H, Harris R, et al Heterogeneity in Risk and Implications for Hepatitis C Reinfection in People Who
Inject Drugs in England.
J Viral Hepat. 2025;32:e14052. PubMedAbstract available
VOELLER AS, Johannessen A, Abebe ZZ, Adugna W, et al The Disease and Economic Burden of HBV and HCV in Ethiopia.
J Viral Hepat. 2025;32:e14053. PubMedAbstract available
GU Y, Gu L, Chen L, Li J, et al Immunotherapy Using HBV Vaccine Pulsed DCs and Induced T-Cells Combined Antiviral
Drugs in Treatment Naive CHB Patients-A Multi-Centre Phase II Study.
J Viral Hepat. 2025;32:e14045. PubMedAbstract available
FURQUIM D'ALMEIDA A, Ho E, Govaerts L, Michielsen P, et al Severe Liver-Related Outcomes in Patients With Hepatitis Delta: Results From a
Multi-Ethnic Multicenter Long-Term Follow-Up Study.
J Viral Hepat. 2025;32:1-15. PubMedAbstract available
ONG E, Xia T, Laing R, Richmond JA, et al Australian Community Pharmacists' Preparedness to Offer and Discuss Hepatitis C
Testing and Treatment With Pharmacy Clients: A Representative Cross-Sectional
Survey.
J Viral Hepat. 2025;32:e70001. PubMedAbstract available
RAMRAKHIANI H, Le MH, Kam L, Nguyen B, et al Long-Term Immunity and Anamnestic Response Following Hepatitis B Vaccination: A
Systematic Review and Meta-Analysis.
J Viral Hepat. 2025;32:e70003. PubMedAbstract available
UKAGEBU CJ, Alao JO, Bamigboye FO, Ukaegbu JC, et al Evaluating Hepatitis B Screening During Pregnancy: A Study on Diagnostic Accuracy
and Infection Control in Nigeria.
J Viral Hepat. 2025;32:e70002. PubMedAbstract available
MENNINI FS, Sciattella P, Simonelli C, Marcellusi A, et al Long-Term Effects of Direct-Acting Antivirals on Hepatitis C: Trends in Liver
Disease-Related Hospitalisations in Italy.
J Viral Hepat. 2025;32:e14061. PubMedAbstract available
ELGRETLI W, Shengir M, Sasson S, Ramanakumar AV, et al Association of MASLD Phenotypes With Liver Fibrosis in Hepatitis C: The Role of
Cardiometabolic Risk Factors.
J Viral Hepat. 2025;32:e70004. PubMedAbstract available
TAN X, Xun L, Yin Q, Chen C, et al Epigenetic Modifications in HBV-Related Hepatocellular Carcinoma.
J Viral Hepat. 2025;32:e14044. PubMedAbstract available
January 2025
QURESHI M A Health Systems Strengthening Approach to Address the High Burden of Hepatitis C
in Pakistan.
J Viral Hepat. 2025;32:e14050. PubMedAbstract available
SAID SS, Shadaker S, McMahon BJ, Armstrong PA, et al Hepatitis B Care and Treatment in Zanzibar, Tanzania: A Demonstration Project
Following 2015 WHO Treatment Guidelines, 2017-2021.
J Viral Hepat. 2025;32:e14051. PubMedAbstract available
WANG B, Wang X, Xiao L, Xian J, et al Misuse of the Lower Limit of Detection in HBV DNA Testing and Anti-HBe Positive
Status Will Significantly Impact the Diagnosis of Occult HBV Infection.
J Viral Hepat. 2025;32:e14046. PubMedAbstract available
CAUSSE X, Potier P, Valery A, Labadie H, et al Predictive Factors for HBsAg Loss in Chronic HBeAg-Negative Hepatitis B Virus
Infection: Insights From a 5-Year French Cohort.
J Viral Hepat. 2025;32:e14041. PubMedAbstract available
LI M, Hunt B, Balani B, Ogedegbe C, et al A US-Based Multi-Site Pilot to Screen Hepatitis B Surface Antigen-Positive
Patients for Hepatitis D.
J Viral Hepat. 2025;32:e14043. PubMedAbstract available
TSAI YN, Lo JC, Tseng CH, Hsieh SC, et al Changes in Serum Rheumatoid Factor Following Eradication of Hepatitis C Virus
Infection With Interferon or Direct Antiviral Therapy.
J Viral Hepat. 2025;32:1-8. PubMedAbstract available
SAWALMEH A, Johansson EW, Kostas D, Hjaijeh D, et al Hepatitis B Patients' Adherence to Treatment in Relation to Knowledge, Attitudes,
and Practices (KAP) in the West Bank, Palestine, 2022-2023.
J Viral Hepat. 2025;32:e14055. PubMedAbstract available
POOROLAJAL J, Shadi Y, Heshmati B Interaction Between Hepatitis B, Hepatitis C and Alcohol in the Development of
Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
J Viral Hepat. 2025;32:e14042. PubMedAbstract available
PARLAR YE, Gulnar MO, Kirmizigul B, Gencdal G, et al The Course of COVID-19 Infection in Patients With Chronic Hepatitis Delta.
J Viral Hepat. 2025;32:e14054. PubMedAbstract available
December 2024
BERTOLETTI A The immune response in chronic HBV infection.
J Viral Hepat. 2024;31 Suppl 2:43-55. PubMedAbstract available
VO-QUANG E, Lemoine M Global elimination of HBV: Is it really achievable?
J Viral Hepat. 2024;31 Suppl 2. PubMedAbstract available
LIM YS Treatment decisions based on HBV DNA.
J Viral Hepat. 2024;31 Suppl 2:36-42. PubMedAbstract available
November 2024
PARK Y, Heo J, Kang D, Gwak GY, et al Impact of Maternal Hepatitis B Virus Infection on Congenital Heart Disease Risk
in Offspring: A National Cohort Study.
J Viral Hepat. 2024 Nov 26. doi: 10.1111/jvh.14036. PubMedAbstract available
ROSECRANS A, Harris R, Clair AS, Rice M, et al Challenges and Opportunities for Treating Hepatitis C Amongst People Who Use
Drugs: Experience of an Integrated Mobile Clinic in Baltimore City.
J Viral Hepat. 2024 Nov 26. doi: 10.1111/jvh.14038. PubMedAbstract available
YEW KC, Sim ASY, Hawkins R, Acharyya S, et al Real-World Evaluation of Point-of-Care Testing for Hepatitis C Antibodies:
Navigating Hepatitis C Elimination Effort.
J Viral Hepat. 2024 Nov 22. doi: 10.1111/jvh.14039. PubMedAbstract available
KASSA GM, Weldemariam AG, Abrahim SA, French CE, et al Seroprevalence of Hepatitis C in Ethiopia: First National Study Based on the 2016
Ethiopian Demographic and Health Survey.
J Viral Hepat. 2024 Nov 21. doi: 10.1111/jvh.14037. PubMedAbstract available
FURL R, Scarsi KK, Sayles H, Anderson M, et al Preferences and Feasibility of Long-Acting Technologies for the Treatment of
Hepatitis C Virus: A Survey of Patients in Diverse Low- and Middle-Income
Countries.
J Viral Hepat. 2024 Nov 15. doi: 10.1111/jvh.14031. PubMedAbstract available
ANDANI A, Mellou K, Dewda P, Eeuwijk J, et al Evolution and Impact of Hepatitis A Epidemiology in Europe-Systematic Literature
Review of the Last 20 Years.
J Viral Hepat. 2024 Nov 11. doi: 10.1111/jvh.14030. PubMedAbstract available
WONG GL Updated Guidelines for the Prevention and Management of Chronic Hepatitis B-World
Health Organization 2024 Compared With China 2022 HBV Guidelines.
J Viral Hepat. 2024 Nov 6. doi: 10.1111/jvh.14032. PubMedAbstract available
DIRKS M, Hennemann AK, Grosse GM, Beer A, et al Long-Term Follow-Up of Neuropsychiatric Symptoms After Sustained Virological
Response to Interferon-Free and Interferon-Based Hepatitis C Virus Treatment.
J Viral Hepat. 2024 Nov 6. doi: 10.1111/jvh.14033. PubMedAbstract available
DAS S, Sood V, Rastogi A, Agarwal N, et al Clinico-Pathological Spectrum of Hepatitis A Virus-Induced Autoimmune-Like
Hepatitis in Children.
J Viral Hepat. 2024 Nov 1. doi: 10.1111/jvh.14028. PubMedAbstract available
October 2024
ETOORI D, Cococcia S, Srivastava A, Flanagan S, et al The Camden and Islington Viral Hepatitis Identification Tool (CIVHIT): Use of a
Clinical Database Case-Finding Tool for Hepatitis B, Hepatitis C and HIV in
Primary Care.
J Viral Hepat. 2024 Oct 24. doi: 10.1111/jvh.14027. PubMedAbstract available
ALI I, Muhammad S, Naqvi SSZH, Wei L, et al Hepatitis B Virus-Associated Liver Carcinoma: The Role of Iron Metabolism and Its
Modulation.
J Viral Hepat. 2024 Oct 24. doi: 10.1111/jvh.14016. PubMedAbstract available
GINNANE JF, Scott N, Radley A, Dillon JF, et al Cost-Effectiveness of Treating Hepatitis C in Clients on Opioid Agonist Therapy
in Community Pharmacies Compared to Primary Healthcare in Australia.
J Viral Hepat. 2024 Oct 23. doi: 10.1111/jvh.14015. PubMedAbstract available
MARTIN MT, Hietpas AR, Novak JL, Deming P, et al A National Survey of Pharmacist Involvement in Hepatitis C Virus Management in
the United States.
J Viral Hepat. 2024 Oct 22. doi: 10.1111/jvh.14014. PubMedAbstract available
YI S, Wiesmann C, Truong D, Sharma S, et al Community Pop-Up Clinic: Cascade of Care and HCV Treatment of Vancouver's
Inner-City PWID Populations.
J Viral Hepat. 2024 Oct 19. doi: 10.1111/jvh.14023. PubMedAbstract available
OHLENDORF V, Wubbolding M, Honer Zu Siederdissen C, Bremer B, et al Limited Value of HBV-RNA for Relapse Prediction After Nucleos(t)ide Analogue
Withdrawal in HBeAg-negative Hepatitis B Patients.
J Viral Hepat. 2024 Oct 19. doi: 10.1111/jvh.14026. PubMedAbstract available
SIMMONS R, Harris R, Lim AG, Leeman D, et al Estimating Prevalence and Number of People With Chronic Hepatitis B: A Multiplier
Method Based on Public Health Surveillance Data in UK (2015-2021).
J Viral Hepat. 2024 Oct 16. doi: 10.1111/jvh.14019. PubMedAbstract available
IWADARE T, Kimura T, Sugiura A, Okumura T, et al Thrombospondin 2 as a Predictive Biomarker for HCC in Hepatitis C Patients: A
Longitudinal Study Following DAA Therapy.
J Viral Hepat. 2024 Oct 15. doi: 10.1111/jvh.14025. PubMedAbstract available
BALIASHVILI D, Merabishvili T, Tskhomelidze I, Tsereteli M, et al Evaluation of Hepatitis C Virus Transmission Through Endoscopy Procedures in the
Country of Georgia.
J Viral Hepat. 2024 Oct 14. doi: 10.1111/jvh.14022. PubMedAbstract available
ZAKALASHVILI M, Surguladze S, Baliashvili D, Zarkua J, et al Evaluation of Knowledge, Attitudes and Practices for Hepatitis B Virus Infection
Among Primary Healthcare Physicians in Georgia.
J Viral Hepat. 2024 Oct 10. doi: 10.1111/jvh.14011. PubMedAbstract available
BUTT AA, Yan P, Iwnetu R, Malik AA, et al Hepatitis Delta Coinfection Rates and All-Cause Mortality Among Hepatitis
B-Infected Veterans in the USA.
J Viral Hepat. 2024 Oct 9. doi: 10.1111/jvh.14021. PubMedAbstract available
CHEN Y, Zhang X, Yan X, Wang L, et al A Programme of Hepatitis C Surveillance With Active Linkage to Care (HEAL) for
Inpatients in Two Tertiary Hospitals in Jiangsu, China.
J Viral Hepat. 2024 Oct 9. doi: 10.1111/jvh.14020. PubMedAbstract available
LU Z, Sun YM, Chen S, Meng T, et al Multiple Low-Level Viraemia Suggest Hindered Liver Fibrosis Regression in Chronic
Hepatitis B Patients During Antiviral Therapy.
J Viral Hepat. 2024 Oct 7. doi: 10.1111/jvh.14012. PubMedAbstract available
PHAW NA, Rayner D, Johnson A, Thompson C, et al Harm Minimisation and Other Preventative Measures Must Improve to Reduce
Transmission of Hepatitis C in Prisons.
J Viral Hepat. 2024 Oct 7. doi: 10.1111/jvh.14017. PubMed
BULDUKOGLU OC, Ocal S, Cekin AH Disparities in the Detection, Diagnosing and Treatment of Hepatitis B Among
Females.
J Viral Hepat. 2024 Oct 5. doi: 10.1111/jvh.14013. PubMed
WAN Y, Yin S, Wu C Reply: Regarding the Predictive Role of CXCL16 in Liver Inflammation in Chronic
Hepatitis B Patients.
J Viral Hepat. 2024 Oct 5. doi: 10.1111/jvh.13996. PubMed
ZHANG HL, Nemeth H, Woodhouse EW, Davenport CA, et al Prevalence of and Risk Factors for Liver Enzyme Elevation After Hepatitis C
Virologic Cure.
J Viral Hepat. 2024 Oct 3. doi: 10.1111/jvh.14009. PubMedAbstract available
PATEL P, Wells MT, Wethington E, Shapiro M, et al United States Provider Experiences With Telemedicine for Hepatitis C Treatment: A
Nationwide Survey.
J Viral Hepat. 2024 Oct 1. doi: 10.1111/jvh.14010. PubMedAbstract available
MAKUZA JD, Wong S, Morrow RL, Binka M, et al Impact of COVID-19 pandemic on hepatocellular carcinoma surveillance in British
Columbia, Canada: An interrupted time series study.
J Viral Hepat. 2024;31:592-600. PubMedAbstract available
September 2024
TULENKO SE, Ngimbi P, Mwandagalirwa K, Tabala M, et al Immunogenicity of a Birth Dose of Hepatitis B Vaccine in Kinshasa, Democratic
Republic of Congo: A Randomised, Controlled Trial.
J Viral Hepat. 2024 Sep 24. doi: 10.1111/jvh.14003. PubMedAbstract available
ZOVICH B, Patel P, Tu T, Wang S, et al Perspectives of People Living With Chronic Hepatitis D: Impact of Disease and
Unmet Needs Along the Care Cascade.
J Viral Hepat. 2024 Sep 17. doi: 10.1111/jvh.14005. PubMedAbstract available
SONG Y, Chen H, Li J, Zhong F, et al Lower Serum Albumin Level: A Prospective Risk Predictor of Hepatocellular
Carcinoma in Patients With Chronic Hepatitis B Virus Infection.
J Viral Hepat. 2024 Sep 16. doi: 10.1111/jvh.14008. PubMedAbstract available
LIANG LY, Yip TC, Lai JC, Lam AS, et al Dynamic Changes in ELF Score Predict Hepatocellular Carcinoma in Chronic
Hepatitis B Patients Receiving Antiviral Treatment.
J Viral Hepat. 2024 Sep 10. doi: 10.1111/jvh.14004. PubMedAbstract available
BARRE T, Parlati L, Bourliere M, Ramier C, et al Socioeconomic Deprivation Weighs Heavily on Liver Fibrosis and Mortality After
Hepatitis C Cure (ANRS CO22 Hepather).
J Viral Hepat. 2024 Sep 10. doi: 10.1111/jvh.14006. PubMedAbstract available
KWOK TY, Hui RW, Mao X, Ling GS, et al Cigarette Smoking Is Associated With Lower Chance of Hepatitis B Surface Antigen
Seroclearance and Altered Host Immunity.
J Viral Hepat. 2024 Sep 9. doi: 10.1111/jvh.14007. PubMedAbstract available
GRANTZ KH, Cepeda J, Astemborski J, Kirk GD, et al Individual Heterogeneity and Trends in Hepatitis C Infection Risk Among People
Who Inject Drugs: A Longitudinal Analysis.
J Viral Hepat. 2024 Sep 5. doi: 10.1111/jvh.13999. PubMedAbstract available
HOFMEISTER MG, Ly KN, Yin S, Spradling PR, et al Evolving Characteristics of Decedents With Hepatitis A Listed as a Cause of
Death, United States, 2011-2021.
J Viral Hepat. 2024 Sep 3. doi: 10.1111/jvh.14002. PubMedAbstract available
August 2024
PAK K, Ibrahim B, Saab S Safety of Tenofovir Disoproxil Fumarate Among Breastfeeding Infants of Patients
With Chronic Hepatitis B: A Systematic Review.
J Viral Hepat. 2024 Aug 29. doi: 10.1111/jvh.14001. PubMedAbstract available
MAHAJAN A, Kharawala S, Desai S, Kendrick S, et al Association of Hepatitis B Surface Antigen Levels With Long-Term Complications in
Chronic Hepatitis B Virus Infection: A Systematic Literature Review.
J Viral Hepat. 2024 Aug 16. doi: 10.1111/jvh.13988. PubMedAbstract available
SACHAR Y, Congly SE, Burak KW, Manko A, et al Epidemiology, Treatment Patterns and Survival in Canadian Patients With Chronic
Hepatitis B-Related Hepatocellular Carcinoma.
J Viral Hepat. 2024 Aug 16. doi: 10.1111/jvh.13989. PubMedAbstract available
WEI B, Li H, Cheng M, Yang Y, et al NLRP3 Inflammasome Activation Mediates Hepatitis E Virus-Induced
Neuroinflammation.
J Viral Hepat. 2024 Aug 13. doi: 10.1111/jvh.13998. PubMedAbstract available
THORNTON KA, Deming PD, Archer GRD, Ceniceros JA, et al Expanding Hepatitis C Virus Treatment in the New Mexico State Prison System:
Using the ECHO Model for Provider and Prison Peer Education.
J Viral Hepat. 2024 Aug 13. doi: 10.1111/jvh.13997. PubMedAbstract available
IMSIROVIC H, Macphail G, Conway B, Fraser C, et al Mixed-Genotype HCV Direct Acting Antiviral Outcomes: A CANUHC Analysis.
J Viral Hepat. 2024 Aug 12. doi: 10.1111/jvh.13995. PubMedAbstract available
WASUWANICH P, Wen TS, Egerman RS, Karnsakul W, et al Epidemiology and Outcomes of Hepatitis E Virus-Associated Hospitalisations in the
United States With a Focus on Pregnancy: A Nationwide Population Study,
1998-2020.
J Viral Hepat. 2024 Aug 11. doi: 10.1111/jvh.13994. PubMedAbstract available
CAVIGLIA GP, Casalone E, Olivero A, Birolo G, et al MiRNome Profiling of Circulating Extracellular Vesicles in Patients With Chronic
Hepatitis D Undergoing Pegylated Interferon Alpha Treatment.
J Viral Hepat. 2024 Aug 11. doi: 10.1111/jvh.14000. PubMedAbstract available
EL EKIABY M, Tanaka J, van Drimmelen H, Allain JP, et al Infectivity of Hepatitis B Virus Surface Antigen-Positive Plasma With
Undetectable HBV-DNA: Can HBsAg Screening Be Discontinued in Egyptian Blood
Donors?
J Viral Hepat. 2024 Aug 10. doi: 10.1111/jvh.13990. PubMedAbstract available
RUPASINGHE D, Choi JY, Kumarasamy N, Pujari S, et al Post-Diagnosis HCV RNA Testing Rates Prior to HCV Treatment Among People Living
With HIV With HCV Antibody Positivity in the Asia-Pacific Region.
J Viral Hepat. 2024 Aug 8. doi: 10.1111/jvh.13993. PubMedAbstract available
PATEL NH, Lucko A, Vachon A, Doucette KE, et al Assessment of HBV variants and novel viral and immune biomarkers in chronic
hepatitis B patients with metabolic dysfunction associated steatotic liver
disease.
J Viral Hepat. 2024 Aug 7. doi: 10.1111/jvh.13979. PubMedAbstract available
HAMA SA, Sirwan R, Abubakr M, Ahmed GS, et al Clinical Prevalence of Hepatitis D Virus Among Hepatitis B Patients in
Sulaymaniyah Governorate, Northern Iraq.
J Viral Hepat. 2024 Aug 7. doi: 10.1111/jvh.13987. PubMedAbstract available
FLISIAK R, Zarebska-Michaluk D, Janczewska E, Parfieniuk-Kowerda A, et al Sustained Virological Response After Early Discontinuation of Hepatitis C
Treatment.
J Viral Hepat. 2024 Aug 7. doi: 10.1111/jvh.13991. PubMedAbstract available
WONG RJ, Liao M, Chen Y, Kwan M, et al Outcomes of a 1-Year Pilot Study Implementing Universal Hepatitis Delta Virus
Testing Among Veterans With Chronic Hepatitis B.
J Viral Hepat. 2024 Aug 5. doi: 10.1111/jvh.13992. PubMedAbstract available
July 2024
YENDEWA GA, Salata RA, Olasehinde T, Mulindwa F, et al Self-reported hepatitis B testing among noninstitutionalized adults in the United
States before the implementation of universal screening, 2013-2017: A nationwide
population-based study.
J Viral Hepat. 2024 Jul 30. doi: 10.1111/jvh.13985. PubMedAbstract available
STASI C, Pacifici M, Puglia M, Voller F, et al Severe acute hepatitis of unknown origin in children: Is it still a mystery? What
role does adenovirus play?
J Viral Hepat. 2024 Jul 29. doi: 10.1111/jvh.13978. PubMedAbstract available
TRAMONTI FANTOZZI MP, Ceccarelli L, Petri D, De Vita E, et al Hepatitis C epidemiology and treatment outcomes in Italy: Impact of the DAA era
and the COVID-19 pandemic.
J Viral Hepat. 2024 Jul 27. doi: 10.1111/jvh.13983. PubMedAbstract available
ALAMNEH TS, Walker JG, Lim AG, Alam E, et al Changes in the prevalence of hepatitis B and C viral infections in Sindh
province, Pakistan: Findings from two sero-surveys in 2007 and 2019.
J Viral Hepat. 2024 Jul 26. doi: 10.1111/jvh.13986. PubMedAbstract available
CHEN B, Iqbal U, Desai SK, Gries J, et al The role of treatment of hepatitis C with direct-acting antiviral agents on
glycaemic control in diabetic patients: An updated systematic review and
meta-analysis.
J Viral Hepat. 2024 Jul 24. doi: 10.1111/jvh.13984. PubMedAbstract available
HUTTON DW, Toy M, Yang D, Zhang H, et al Modelling the potential impact of global hepatitis B vaccination on the burden of
chronic hepatitis B in the United States.
J Viral Hepat. 2024 Jul 22. doi: 10.1111/jvh.13982. PubMedAbstract available
BEYDOUN HA, Tsai J Screening rates for hepatitis B and C among low-income US veterans: Data from the
National Veteran Homeless and Other Poverty Experiences Study.
J Viral Hepat. 2024 Jul 10. doi: 10.1111/jvh.13981. PubMedAbstract available
HUANG D, Lai H, Zhu Z, Yu H, et al Inverse relationship between HBV DNA levels and liver histopathological changes
in immune-tolerant CHB patients.
J Viral Hepat. 2024;31:363-371. PubMedAbstract available
June 2024
ZHANG J, Zhang Y Regarding the predictive role of CXCL16 in liver inflammation in chronic
hepatitis B patients.
J Viral Hepat. 2024 Jun 10. doi: 10.1111/jvh.13976. PubMed
LI T, Chen Y, Zhang Y, Wu S, et al Elevated hepatitis B virus RNA levels in HBeAg-positive patients with low-level
viraemia or previous low-level viraemia.
J Viral Hepat. 2024 Jun 10. doi: 10.1111/jvh.13957. PubMedAbstract available
COSTE M, Diouf A, Ndong C, Diouf A, et al Investigating linkage to care following community-based screening for hepatitis B
virus in rural Senegal: A mixed methods study.
J Viral Hepat. 2024 Jun 5. doi: 10.1111/jvh.13977. PubMedAbstract available
CLIPMAN SJ, Mehta SH, Mohapatra S, Srikrishnan AK, et al Network-based strategies to combat HCV: Examining social and spatial drivers of
transmission among PWID in New Delhi.
J Viral Hepat. 2024 Jun 4. doi: 10.1111/jvh.13960. PubMedAbstract available
MOUSAVI S, Alavi M, Delavari A, Poustchi H, et al Towards hepatitis C virus elimination in Iran: A blueprint for comprehensive
strategies.
J Viral Hepat. 2024 Jun 3. doi: 10.1111/jvh.13975. PubMedAbstract available
May 2024
KHAN N, Kakakhel S, Malik A, Nigar K, et al Genetic substructure and host-specific natural selection trend across
vaccine-candidate ORF-2 capsid protein of hepatitis-E virus.
J Viral Hepat. 2024 May 28. doi: 10.1111/jvh.13959. PubMedAbstract available
DOWNS LO, Kabagambe K, Williams S, Waddilove E, et al Peer support for people living with hepatitis B virus-A foundation for treatment
expansion.
J Viral Hepat. 2024 May 26. doi: 10.1111/jvh.13952. PubMedAbstract available
SHAYAN NA, Rahimi A, Stranges S, Thind A, et al Factors affecting quality of life in hepatitis B patients in Herat, Afghanistan:
A case-control study.
J Viral Hepat. 2024 May 24. doi: 10.1111/jvh.13961. PubMedAbstract available
KOCHAKSARAEI GS, Yang F, Seow CH, Barkema HW, et al Epidemiology, linkage to care and natural history of women of childbearing age
with chronic hepatitis B: A population-based study.
J Viral Hepat. 2024 May 21. doi: 10.1111/jvh.13954. PubMedAbstract available
GU Q, Yin S, Tong X, Rui F, et al Current research insights into the role of CTLA-4 in hepatitis B virus (HBV)
infection.
J Viral Hepat. 2024 May 21. doi: 10.1111/jvh.13958. PubMedAbstract available
QURESHI H, Mahmood H, Nasir Z, Siddique S, et al A novel test and treat program for hepatitis C virus infection utilizing HCV core
antigen testing, among police and general population, Islamabad, Pakistan, 2022.
J Viral Hepat. 2024 May 21. doi: 10.1111/jvh.13953. PubMedAbstract available
LE GUILLOU-GUILLEMETTE H, Pivert A, ElBara A, Vall M, et al Prevalence, clinical and virological characteristics and short-term prognosis of
hepatitis delta infection among patients with HIV/HBV in Nouakchott, Mauritania.
J Viral Hepat. 2024 May 21. doi: 10.1111/jvh.13950. PubMedAbstract available
IRVIN R, Landry G, Jones MR, James A, et al High prevalence of hepatitis C virus infection among incarcerated persons:
Results from the Louisiana Hepatitis C Elimination Plan's opt-out testing program
in prisons.
J Viral Hepat. 2024 May 17. doi: 10.1111/jvh.13941. PubMedAbstract available
MESZAROS M, Coursier S, Nagot N, Moulis L, et al Screening for hepatitis C virus at the time of mammography using rapid diagnostic
tests in women aged between 50 and 74 years (Mamm'OC NCT05067374).
J Viral Hepat. 2024 May 15. doi: 10.1111/jvh.13947. PubMedAbstract available
ROUSSOS S, Bagos C, Angelopoulos T, Chaikalis S, et al Incidence of primary hepatitis C infection among people who inject drugs during
2012-2020 in Athens, Greece.
J Viral Hepat. 2024 May 14. doi: 10.1111/jvh.13951. PubMedAbstract available
ZHONG W, Zheng J, Yao N, Feng Y, et al Association of HBeAg decline rate from mid-pregnancy to delivery with HBeAg
seroconversion after delivery in hepatitis B virus-infected mothers.
J Viral Hepat. 2024 May 10. doi: 10.1111/jvh.13948. PubMedAbstract available
KUMAR A, Sahu U, Agnihotri G, Dixit A, et al A novel multi-epitope peptide vaccine candidate targeting hepatitis E virus: An
in silico approach.
J Viral Hepat. 2024 May 10. doi: 10.1111/jvh.13949. PubMedAbstract available
MAK LY, Yee LJ, Wong RJ, Ramers CB, et al Hepatocellular carcinoma among patients with chronic hepatitis B in the
indeterminate phase.
J Viral Hepat. 2024 May 8. doi: 10.1111/jvh.13914. PubMedAbstract available
RAZAVI-SHEARER D The economic argument for hepatitis B treatment simplification and expansion.
J Viral Hepat. 2024 May 8. doi: 10.1111/jvh.13920. PubMedAbstract available
April 2024
ALI M, Tucker JD, Kpokiri EE, Wu D, et al Crowdsourcing to increase hepatitis B and C testing and reduce hepatitis stigma
among medical students in Bangladesh.
J Viral Hepat. 2024 Apr 28. doi: 10.1111/jvh.13945. PubMedAbstract available
HOLT B, Mendoza J, Nguyen H, Doan D, et al Barriers and enablers to people-centred viral hepatitis care in Vietnam and the
Philippines: Results of a patient journey mapping study.
J Viral Hepat. 2024 Apr 23. doi: 10.1111/jvh.13944. PubMedAbstract available
ALQAHTANI SA, Yilmaz Y, El-Kassas M, Alswat K, et al Clinical and patient-reported outcomes in patients with chronic hepatitis B and C
and non-alcoholic fatty liver disease from real-world practices in Saudi Arabia,
Turkey and Egypt.
J Viral Hepat. 2024 Apr 15. doi: 10.1111/jvh.13935. PubMedAbstract available
WONG RJ, Hirode G, Feld J, Wong SS, et al An updated assessment of hepatitis delta prevalence among adults in Canada: A
meta-analysis.
J Viral Hepat. 2024 Apr 15. doi: 10.1111/jvh.13939. PubMedAbstract available
OLTMANNS C, Bremer B, Kusche L, Stal P, et al Elevation of S2-bound alpha1-acid glycoprotein is associated with chronic hepatitis C
virus infection and hepatocellular carcinoma.
J Viral Hepat. 2024 Apr 12. doi: 10.1111/jvh.13943. PubMedAbstract available
RUI F, Garcia E, Hu X, Ni W, et al Antiviral therapy response in patients with chronic hepatitis B and fatty liver:
A systematic review and meta-analysis.
J Viral Hepat. 2024 Apr 8. doi: 10.1111/jvh.13942. PubMedAbstract available
SARAVANAN S, Shankar EM, Vignesh R, Ganesh PS, et al Occult hepatitis B virus infection and current perspectives on global WHO 2030
eradication.
J Viral Hepat. 2024 Apr 5. doi: 10.1111/jvh.13928. PubMedAbstract available
MAINA A, Foster GR Hepatitis after gene therapy, what are the possible causes?
J Viral Hepat. 2024;31 Suppl 1:14-20. PubMedAbstract available
March 2024
GUPTA N, Swindells S, Scarsi KK, Furl R, et al Preferences and feasibility of long-acting technologies for treatment of
hepatitis C virus in low- and middle-income countries: A survey of providers and
policymakers.
J Viral Hepat. 2024 Mar 28. doi: 10.1111/jvh.13921. PubMedAbstract available
NAVEED A, Khalid A, Janjua N, Cloherty GA, et al Performance of HCV core antigen and PCR testing in a predominantly genotype 3
population.
J Viral Hepat. 2024 Mar 14. doi: 10.1111/jvh.13937. PubMedAbstract available
DOBROWOLSKA K, Pawlowska M, Zarebska-Michaluk D, Rzymski P, et al Direct-acting antivirals in women of reproductive age infected with hepatitis C
virus.
J Viral Hepat. 2024 Mar 14. doi: 10.1111/jvh.13936. PubMedAbstract available
HAVENS JR, Lofwall MR, Young AM, Staton M, et al Predictors of engagement in screening for a hepatitis C virus (HCV) treatment
trial in a rural Appalachian community.
J Viral Hepat. 2024 Mar 4. doi: 10.1111/jvh.13933. PubMedAbstract available
SULKOWSKI MS, Martinez A, Tyson GL, Scholz K, et al Leveraging opportunities for treatment/user simplicity (LOTUS): Navigating the
current treatment landscape for achieving hepatitis C virus elimination among
persons who inject drugs.
J Viral Hepat. 2024 Mar 3. doi: 10.1111/jvh.13927. PubMedAbstract available
February 2024
KATCHER JG, Klassen AC, Hann HW, Chang M, et al Racial discrimination, knowledge, and health outcomes: The mediating role of
hepatitis B-related stigma among patients with chronic hepatitis B.
J Viral Hepat. 2024 Feb 26. doi: 10.1111/jvh.13932. PubMedAbstract available
IQBAL HS, Gunaratne MP, Loeb TA, Pradeep A, et al High prevalence of hepatitis B virus among MSM living with HIV in India.
J Viral Hepat. 2024 Feb 22. doi: 10.1111/jvh.13929. PubMedAbstract available
WOLFSON-STOFKO B, Hirode G, Vanderhoff A, Karkada J, et al Real-world hepatitis C prevalence and treatment uptake at opioid agonist therapy
clinics in Ontario, Canada.
J Viral Hepat. 2024 Feb 22. doi: 10.1111/jvh.13931. PubMedAbstract available
FRYE K, Davis A, Darby R, McDaniel K, et al A contactless cure: Leveraging telehealth to improve hepatitis C treatment at a
safety-net hospital.
J Viral Hepat. 2024 Feb 18. doi: 10.1111/jvh.13913. PubMedAbstract available
WALTER LA, Prados M, Lloyd A, Sontheimer S, et al Birth cohort-specific consideration in an Emergency Department Hepatitis C
Testing Programme: A description of age-related characteristics and outcomes.
J Viral Hepat. 2024 Feb 17. doi: 10.1111/jvh.13930. PubMedAbstract available
TULLY DC, Power KA, Sarette J, Stopka TJ, et al Validation of dried blood spots for capturing hepatitis C virus diversity for
genomic surveillance.
J Viral Hepat. 2024 Feb 16. doi: 10.1111/jvh.13924. PubMedAbstract available
WU L, Yang Z, Zheng M Biogenesis of serum HBV RNA and clinical phenomena of serum HBV RNA in chronic
hepatitis B patients before and after receiving nucleos(t)ide analogues therapy.
J Viral Hepat. 2024 Feb 8. doi: 10.1111/jvh.13926. PubMedAbstract available
EPSTEIN RL, Buzzee B, White LF, Feld JJ, et al Test characteristics for combining non-invasive liver fibrosis staging modalities
in individuals with Hepatitis C virus.
J Viral Hepat. 2024 Feb 7. doi: 10.1111/jvh.13925. PubMedAbstract available
LV R, Lu Y, Xiang W, Meng M, et al Chronic viral hepatitis C micro-elimination program using telemedicine in Guigang
city.
J Viral Hepat. 2024 Feb 7. doi: 10.1111/jvh.13922. PubMedAbstract available
January 2024
FARAG MS, van Campenhout MJH, Sonneveld MJ, Fung S, et al Addition of PEG-interferon to long-term nucleos(t)ide analogue therapy enhances
HBsAg decline and clearance in HBeAg-negative chronic hepatitis B: Multicentre
Randomized Trial (PAS Study).
J Viral Hepat. 2024 Jan 19. doi: 10.1111/jvh.13918. PubMedAbstract available
POLLOCK TS, Robert CA, Seybold DJ, Hur M, et al Prevalence of hepatitis C among pregnant women in an Appalachian population.
J Viral Hepat. 2024 Jan 18. doi: 10.1111/jvh.13911. PubMedAbstract available
QIN W, Shao L, Wang J, Zhang H, et al Persistence of antibodies 5 years after hepatitis B vaccination in preterm birth
children: A retrospective cohort study using real-world data.
J Viral Hepat. 2024 Jan 18. doi: 10.1111/jvh.13908. PubMedAbstract available
HIBBERT M, Simmons R, Sabin CA, Mandal S, et al Identifying missed opportunities for hepatitis C virus antenatal testing and
diagnosis in England.
J Viral Hepat. 2024 Jan 4. doi: 10.1111/jvh.13906. PubMedAbstract available
QURESHI H, Duran AC, Mahmood H, Sarwar Z, et al Context-dependent accuracy of the cobas plasma separation card for HCV RNA viral
load measurement.
J Viral Hepat. 2024 Jan 2. doi: 10.1111/jvh.13910. PubMedAbstract available
HIGE S, Aoki K, Nakamoto D, Flaherty JF, et al Real-world safety and effectiveness of tenofovir alamenamide for 144 weeks in
Japanese patients with chronic hepatitis B.
J Viral Hepat. 2024 Jan 1. doi: 10.1111/jvh.13912. PubMedAbstract available
December 2023
ALQAHTANI SA, Stepanova M, Al Shabeeb R, Eberly KL, et al The impact of hepatitis B and C positive serologies on the outcomes of
non-hepatic solid organ transplantation in the United States.
J Viral Hepat. 2023 Dec 29. doi: 10.1111/jvh.13916. PubMedAbstract available
O'KEEFE D, Jacka D, Douglass C, Gunn J, et al Distribution of rapid HCV antibody self-test kits via needle/syringe dispensing
machines: Implementation and evaluation of the Vend-C pilot study in Melbourne,
Australia.
J Viral Hepat. 2023 Dec 29. doi: 10.1111/jvh.13909. PubMedAbstract available
TOYODA H, Koshiyama Y, Yasuda S, Kumada T, et al Effect of previous infection with hepatitis B virus on the incidence of
hepatocellular carcinoma after sustained virologic response in patients with
chronic hepatitis C virus infection.
J Viral Hepat. 2023 Dec 26. doi: 10.1111/jvh.13907. PubMedAbstract available
WAN Y, Mao M, Li M, Liu J, et al Serum CXCL16: A new predictor of liver inflammation in patients with chronic
hepatitis B.
J Viral Hepat. 2023 Dec 25. doi: 10.1111/jvh.13905. PubMedAbstract available
ZHOU S, Qi K, Bersoff-Matcha SJ, Mishra P, et al Sex-related difference analyses of efficacy and safety in clinical trials of
direct-acting antivirals to treat chronic HCV genotype 1 and 3 infections.
J Viral Hepat. 2023 Dec 19. doi: 10.1111/jvh.13901. PubMedAbstract available
YANG Q, Lin T, Zhao Y, Qiu Y, et al International disease burden of acute viral hepatitis among adolescents and young
adults: An observational study.
J Viral Hepat. 2023 Dec 8. doi: 10.1111/jvh.13903. PubMedAbstract available
WASUWANICH P, So JM, Rajborirug S, Karnsakul W, et al Hepatitis A hospitalisations in the United States and risk factors for inpatient
mortality: A nationwide population study, 1998-2020.
J Viral Hepat. 2023 Dec 8. doi: 10.1111/jvh.13902. PubMedAbstract available
RAZAVI H, Blach S, Bregenzer A, Bruggmann P, et al Assessing the hepatitis C epidemiology in Switzerland: It is not that trivial.
J Viral Hepat. 2023 Dec 8. doi: 10.1111/jvh.13904. PubMed
NING Q, Yang T, Guo X, Huang Y, et al CHB patients with rtA181T-mutated HBV infection are associated with higher risk
hepatocellular carcinoma due to increases in mutation rates of tumour suppressor
genes.
J Viral Hepat. 2023;30:951-958. PubMedAbstract available
November 2023
O'SULLIVAN M, Jones AM, Mourad A, Haddadin Y, et al Excellent hepatitis C virus cure rates despite increasing complexity of people
who use drugs: Integrated-Test-stage Treat study final outcomes.
J Viral Hepat. 2023 Nov 28. doi: 10.1111/jvh.13897. PubMedAbstract available
DEMIREL A, Uraz S, Deniz Z, Daglilar E, et al Epidemiology of hepatitis D virus infection in Europe: Is it vanishing?
J Viral Hepat. 2023 Nov 14. doi: 10.1111/jvh.13899. PubMedAbstract available
HAJARIZADEH B, Carson JM, Byrne M, Grebely J, et al Incidence of hepatitis C virus infection in the prison setting: The SToP-C study.
J Viral Hepat. 2023 Nov 7. doi: 10.1111/jvh.13895. PubMedAbstract available
NATOUR RT, Midlej A, Mahajna E, Kopelman Y, et al Chronic hepatitis B beyond clinical burden: Psychosocial effects and impact on
quality of life.
J Viral Hepat. 2023 Nov 3. doi: 10.1111/jvh.13894. PubMedAbstract available
TRELOAR C, Rance J, Bryant J, Lafferty L, et al "There's too much power in this number. It's freaking the whole response out":
the views of key informants on evidence and targets to achieve hepatitis C
elimination goals in Australia.
J Viral Hepat. 2023 Nov 2. doi: 10.1111/jvh.13896. PubMedAbstract available
October 2023
MAK LY, Koffas A, Dolman GE, Saleh H, et al Role of HBsAg levels in guiding hepatitis B virus prophylaxis in pregnancy:
Insights from a multi-ethnic cohort.
J Viral Hepat. 2023 Oct 26. doi: 10.1111/jvh.13893. PubMedAbstract available
BERTISCH B, Schaetti C, Schmid P, Peter L, et al Chronic hepatitis C virus infections in Switzerland in 2020: Lower than expected
and suggesting achievement of WHO elimination targets.
J Viral Hepat. 2023 Oct 7. doi: 10.1111/jvh.13892. PubMed
VANWOLLEGHEM T, Armstrong PA, Buti M, FitzSimons D, et al The elimination of hepatitis D as a public health problem: Needs and challenges.
J Viral Hepat. 2023 Oct 3. doi: 10.1111/jvh.13891. PubMedAbstract available
VIRTUDAZO MCC, Aquino JB, Arellano RNB, Fortes RA, et al The role of dried blood spot tests in the detection of hepatitis B infection: A
systematic review.
J Viral Hepat. 2023 Oct 3. doi: 10.1111/jvh.13890. PubMedAbstract available
BEGHIN J, Meier-Stephenson V Does hepatitis delta virus have a preference for hepatitis B virus genotype? A
systematic review of the literature.
J Viral Hepat. 2023 Oct 3. doi: 10.1111/jvh.13889. PubMedAbstract available
September 2023
MA NZ, Dai W, Bao X, Bu ZQ, et al Effects of hepatitis B virus infection on the treatment outcomes following in
vitro fertilization/intracytoplasmic sperm injection: An analysis of 21,999 first
embryo transfer cycles.
J Viral Hepat. 2023 Sep 23. doi: 10.1111/jvh.13878. PubMedAbstract available
EVANS KN, Vettese T, Wortley PM, Gandhi AP, et al HIV and HCV testing at clinical encounters among people who inject drugs,
2013-2018-Opportunities for increased testing and prevention.
J Viral Hepat. 2023 Sep 19. doi: 10.1111/jvh.13877. PubMedAbstract available
HE H, Wu Y, Jia Z, Xu H, et al Risk-stratified approach by aMAP score for community population infected with
hepatitis B and C to guide subsequent liver cancer screening practice: A cohort
study with 10-year follow-up.
J Viral Hepat. 2023 Sep 18. doi: 10.1111/jvh.13884. PubMedAbstract available
CAROLINE A, Kate M, Roberts M, Ryan J, et al What is the impact of a Hepatitis C 'test, trace and treat' pilot using peer
workers?
J Viral Hepat. 2023 Sep 18. doi: 10.1111/jvh.13888. PubMedAbstract available
JOHNSON A, Shearer J, Thompson C, Jelley R, et al Impact of 5 years of hepatitis C testing and treatment in the North East of
England prisons.
J Viral Hepat. 2023 Sep 12. doi: 10.1111/jvh.13887. PubMedAbstract available
KHAN S, Kumar Y, Sharma C, Gupta SK, et al Dysregulated metabolites and lipids in serum of patients with acute hepatitis E:
A longitudinal study.
J Viral Hepat. 2023 Sep 11. doi: 10.1111/jvh.13885. PubMedAbstract available